Hancock Whitney Corp Has $2.98 Million Stock Holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Hancock Whitney Corp grew its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 5.4% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 193,467 shares of the real estate investment trust’s stock after purchasing an additional 9,911 shares during the quarter. Hancock Whitney Corp owned about 0.08% of Sabra Health Care REIT worth $2,979,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in SBRA. Sei Investments Co. lifted its stake in Sabra Health Care REIT by 6.5% in the second quarter. Sei Investments Co. now owns 116,695 shares of the real estate investment trust’s stock valued at $1,797,000 after buying an additional 7,137 shares during the period. Intech Investment Management LLC acquired a new stake in shares of Sabra Health Care REIT in the 2nd quarter valued at approximately $1,139,000. Hsbc Holdings PLC raised its position in shares of Sabra Health Care REIT by 19.0% in the 2nd quarter. Hsbc Holdings PLC now owns 297,420 shares of the real estate investment trust’s stock valued at $4,573,000 after acquiring an additional 47,473 shares during the period. Waterloo Capital L.P. boosted its stake in Sabra Health Care REIT by 7.2% during the 2nd quarter. Waterloo Capital L.P. now owns 246,342 shares of the real estate investment trust’s stock worth $3,794,000 after acquiring an additional 16,474 shares during the last quarter. Finally, Mercer Global Advisors Inc. ADV grew its holdings in Sabra Health Care REIT by 2.5% during the second quarter. Mercer Global Advisors Inc. ADV now owns 48,448 shares of the real estate investment trust’s stock valued at $746,000 after purchasing an additional 1,168 shares during the period. 99.40% of the stock is currently owned by institutional investors.

Sabra Health Care REIT Stock Up 1.5 %

Shares of Sabra Health Care REIT stock opened at $18.64 on Friday. Sabra Health Care REIT, Inc. has a 52-week low of $12.83 and a 52-week high of $19.32. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.27 and a current ratio of 4.27. The business’s 50 day simple moving average is $16.90 and its 200 day simple moving average is $15.28. The firm has a market cap of $4.32 billion, a PE ratio of 93.20, a P/E/G ratio of 2.71 and a beta of 1.26.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Wednesday, August 7th. The real estate investment trust reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.24). Sabra Health Care REIT had a net margin of 7.83% and a return on equity of 1.87%. The business had revenue of $176.14 million during the quarter, compared to analyst estimates of $166.54 million. During the same quarter last year, the business earned $0.34 earnings per share. Sabra Health Care REIT’s revenue for the quarter was up 9.3% on a year-over-year basis. On average, analysts predict that Sabra Health Care REIT, Inc. will post 1.37 earnings per share for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 19th were paid a dividend of $0.30 per share. The ex-dividend date was Monday, August 19th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.44%. Sabra Health Care REIT’s dividend payout ratio is 600.00%.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the stock. Scotiabank lifted their price target on shares of Sabra Health Care REIT from $15.00 to $17.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. Truist Financial lifted their target price on Sabra Health Care REIT from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Finally, Citigroup raised Sabra Health Care REIT from a “neutral” rating to a “buy” rating and boosted their target price for the company from $17.00 to $20.00 in a research note on Friday, September 13th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $17.30.

Sabra Health Care REIT Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.